Innovative Medtech, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
AnTix Holdings, formerly Innovative MedTech, Inc., reported a net income of $1.27 million for fiscal year 2025, driven by the sale of its SarahCare subsidiaries and a strategic pivot to AI-driven ticketing services.
OTC.Pink
10-K: Innovative MedTech Reports $7.9 Million Net Loss in Fiscal Year 2024 Amidst Operational Challenges
Innovative MedTech, Inc. reported a significant net loss of $7.9 million for the fiscal year ended June 30, 2024, alongside increased operating expenses and ongoing financial challenges.